Neoleukin Therapeutics In...

NASDAQ: NLTX · Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 10:00 PM

Neoleukin Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.88 -0.49 -4.37
PEG Ratio
n/a 0.11 -0.07
PS Ratio
n/a n/a 44.22K
PB Ratio
0.21 0.30 1.86
P/FCF Ratio
-0.93 -0.6 -5.22
P/OCF Ratio
-0.94 -0.62 -5.58
OCF/S Ratio
n/a n/a -7.93K
Debt / Equity Ratio
0.04 0.13 0.09
Quick Ratio
20.84 8.96 16.67
Current Ratio
20.84 8.96 16.67
Asset Turnover
n/a n/a 0.00
Interest Coverage
6.88K -37.36 n/a
Return on Equity
-0.24 -0.61 -0.42
Return on Assets
-0.22 -0.5 -0.37
Return on Invested Capital
-0.26 -0.54 -0.37
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a 1.00
Net Profit Margin
n/a n/a -10.12K
Pretax Profit Margin
n/a n/a -10.12K
Operating Profit Margin
n/a n/a -10.12K
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a -10.12K